Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium.

BACKGROUND: Asthma is associated with increased production of IL-4 and IL-13. OBJECTIVE: Because many of the effects of these cytokines are mediated by activation of signal transducer and activator of transcription 6 (STAT-6), we investigated expression and function of this transcription factor in the airways. METHODS: STAT-6 expression was investigated through use of immunohistochemistry or RT-PCR applied to bronchial biopsy specimens or brushings from normal control or asthmatic subjects. STAT-6 function was investigated by means of Western blotting and ELISA applied to primary epithelial cell cultures. RESULTS: Immunohistochemistry revealed that the bronchial epithelium was the major site of STAT-6 expression, both cytoplasmic and nuclear staining being observed. The level of STAT-6 expression in subjects with mild asthma (median [range] percent epithelial staining, 3.4% [0% to 16.0%]; n = 14) did not differ significantly from that in normal controls (4.7% [0.0% to 20.0%]; n = 11); however, in subjects with severe asthma, epithelial STAT-6 expression (13.7% [4.8% to 25.7%]; n = 9) was increased in comparison with subjects with mild asthma and normal controls (P < .05). RT-PCR analysis showed that epithelial STAT-6 expression was heterogeneous and comprised both full-length STAT-6 and the dominant-negative variant that lacks the SH2 domain. Treatment of primary cultures of bronchial epithelial cells with IL-4 resulted in STAT-6 phosphorylation and stimulation of IL-8 secretion; however, no difference in the responses of epithelial cells was observed between normal (n = 12) and asthmatic (n = 14) donors. CONCLUSION: These data demonstrate expression and activation of STAT-6 in normal and asthmatic bronchial epithelium. The activity of this transcription factor is likely to play a key role in mediating the responses of the bronchial epithelium to T(H)2 cytokines that are characteristic of the asthmatic phenotype.

Bronchial asthma deaths in Jamaica

Many countries have reported an increase in the death rate from bronchial asthma. Evaluation of the situation in Jamaica was undertaken to see if the trend is similar to that reported from elsewhere by analysing deaths for the period 1980 to 1989. There was an increase in the death rate during the period studied, most marked in females in rural areas. Most of the deaths occurred outside medical facilities. The reasons for these trends are not clear.

Bronchial asthma deaths in Jamaica

Many countries have reported an increase in the death rate from bronchial asthma. Evaluation of the situation in Jamaica was undertaken to see if the trend is similar to that reported from elsewhere by analysing deaths for the period 1980 to 1989. There was an increase in the death rate during the period studied, most marked females in rural areas. Most of the deaths occurred outside medical facilities. The reasons for these trends are not clear.(AU)

Bronchial asthma deaths in Jamaica.

Many countries have reported an increase in the death rate from bronchial asthma. Evaluation of the situation in Jamaica was undertaken to see if the trend is similar to that reported from elsewhere by analysing deaths for the period 1980 to 1989. There was an increase in the death rate during the period studied, most marked in females in rural areas. Most of the deaths occurred outside medical facilities. The reasons for these trends are not clear.

Investigation of sequence homology in a group of type-II restriction/modification isoschizomers.

We have dissected the cloned PstI M and R genes to make DNA hybridization probes spanning most of the sequence. These subclones, and also the intact sequence, were used to search for nucleic acid homology by Southern blot in the DNA from twelve organisms which produce PstI isoschizomers. One of these probes, a 206-bp fragment from the N-terminal domain of the endonuclease, showed significant hybridisation in four strains (Escherichia coli strains RFL48, RFL49 and RFL83, and Streptomyces albus P). No significant hybridisation was detected with other parts of the PstI sequences. We have used computer similarity searches to look for homology between the PstI proteins and the known sequences of other type-II systems that recognise different sites. We postulate a possible recognition domain within the M.PstI methyltransferase based on similarity to the M.PaeR7 and M.TaqI methyltransferases.

Aerobic lactate synthesis by cardiac muscle.

Cardiac lactate production under aerobic conditions is absolutely dependent upon the availability of extracellular pyruvate. In the steady state, aerobic lactate output is largely independent of cardiac work load, but increases slightly when octanoate is included in addition to pyruvate in the perfusion fluid. Transient episodes of supra-normal lactate production are seen after sudden increases in cardiac work output, and also after transitions from octanoate to pyruvate in the perfusion media. These pulses of lactate production are invariably associated with the slow activation of pyruvate dehydrogenase in response to a sudden change in cardiac metabolic state, and they are abolished by pre-perfusion with dichloracetate, which converts pyruvate dehydrogenase into the fully active form. A second, additional component of the lactate pulses is sensitive to pre-perfusion with the transaminase inhibitor aminooxyacetate. The size of the second component is markedly dependent upon the precise protocol adopted for the experiment, and these variations suggest that the second component is associated with a major redistribution of cardiac Krebs' cycle intermediates and amino acids following the initial exposure to pyruvate-containing media. Steadystate aerobic lactate production is insensitive to both dichloroacetate and aminooxyacetate, and is thought to result from a direct exchange of malate for oxaloacetate across the heart mitochondrial membranes.